In kidney cancer, protein and mRNA levels for MPC1 and MPC2 are lower in advanced renal cell carcinoma (RCC) tumors compared to normal adjacent tissue [39], and decreased MPC1 expression in RCC correlates with worse survival outcomes [40]. This evidence concerns the gene MPC1 and renal cell carcinoma.